Funding round brings in $15M for Pa. biotech

05/6/2013 | American City Business Journals

AltheRx Pharmaceuticals secured $15 million in its latest funding round. The Exton, Pa.-based firm plans to use the money to bring Solabegron, its lead drug candidate for overactive bladder, into late-stage trials. AltheRx also appointed Jim Bennethum, former executive vice president of Becker Ventures, as its new CEO.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC